36Kr
Latest recorded position: #10 on Aug 3, 2026, 8:31 PM CST.
There are not enough retained observations to calculate a rank change.
Porton Pharma: Subsidiary Obtains Drug Manufacturing License, Qualifying It for Contract Manufacturing of Commercial Cell and Gene Therapy Products
博腾股份：控股子公司取得药品生产许可证，已具备承接细胞与基因治疗产品商业化受托生产的合规资质
ThreadEast first recorded "Porton Pharma: Subsidiary Obtains Drug Manufacturing License, Qualifying It for Contract Manufacturing of Commercial Cell and Gene Therapy Products" on Aug 3, 2026, 8:31 PM CST. It has been observed on 36Kr, with less than one hour between the first and latest recorded appearances.
What the trend data tells us
The English title describes the topic of the source listing. Its appearance in a ranking measures attention within that platform; the ranking alone does not explain the cause of a spike or verify the underlying claim.
This stable URL remains available after a topic leaves a live ranking. Observation span is elapsed time between sightings, not continuous time on a chart. Platforms use different ranking and heat systems; their metrics are not added together.
Original evidence
Source listings
36
#10Last observed rank
Original source